Pretraga

Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1036840

Lack of association of SCN2A rs17183814 polymorphism with the efficacy of lamotrigine monotherapy in patients with focal epilepsy from Herzegovina area, Bosnia and Herzegovina

Pejanović-Škobić, Nataša; Marković, Ivana; Božina, Nada; Bašić, Silvio
Lack of association of SCN2A rs17183814 polymorphism with the efficacy of lamotrigine monotherapy in patients with focal epilepsy from Herzegovina area, Bosnia and Herzegovina // Epilepsy research, 158 (2019), 106221, 4 doi:10.1016/j.eplepsyres.2019.106221 (međunarodna recenzija, članak, znanstveni)

CROSBI ID: 1036840 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Lack of association of SCN2A rs17183814 polymorphism with the efficacy of lamotrigine monotherapy in patients with focal epilepsy from Herzegovina area, Bosnia and Herzegovina

Autori
Pejanović-Škobić, Nataša ; Marković, Ivana ; Božina, Nada ; Bašić, Silvio

Izvornik
Epilepsy research (0920-1211) 158 (2019); 106221, 4

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Epilepsy ; Gene polymorphism ; SCN2A ; Lamotrigine

Sažetak
Objective We assessed the influence of the SCN2A gene polymorphism c.56 G > A rs17183814 on the response to lamotrigine monotherapy in patients with focal epilepsy in Herzegovina area, Bosnia and Herzegovina. Material and methods For SCN2A polymorphism c.56 G > A rs17183814, one hundred patients with epilepsy who were receiving lamotrigine in monotherapy and seventy-one age and sex matched healthy controls were genotyped using TaqMan assay. All patients were Caucasians from the region of Herzegovina, Bosnia and Herzegovina. Genotyping was conducted using a polymerase chain reaction in real time. Patients were divided into two groups: responders and non-responders. Results Of all patients with epilepsy, 33% were non- responders, and 67% were responders. The mean age of non-responders was 38.8 vs. group of responders in which it was 35.2. Mean age of onset of seizures in epilepsy patients was 26.7 for non- responders and 25.4 for responders. In patients with epilepsy, the mean age of seizure onset was 26.7 for non-responders and 25.4 for responders. For SCN2A c.56 G > A gene polymorphism, we did not observe any significant differences in genotypic or allelic frequency between patients with epilepsy and healthy controls. Genotype or allelic frequencies of SCN2A c.56 G > A gene polymorphism did not significantly differ for AG or GG genotypes in the non-responders vs. responders. Conclusion There was no significant association in patients with focal epilepsy between studied genotypes and response to lamotrigine monotherapy in Herzegovina patients with focal epilepsy. However, we need studies in a bigger cohort of patients with epilepsy to be assessed in the future.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA

Ustanove:
Medicinski fakultet, Zagreb,
Klinička bolnica "Dubrava",
Klinički bolnički centar Zagreb,
Fakultet za dentalnu medicinu i zdravstvo, Osijek

Profili:

Avatar Url Silvio Bašić (autor)

Avatar Url Nada Božina (autor)

Avatar Url Ivana Marković (autor)

Poveznice na cjeloviti tekst rada:

doi www.sciencedirect.com

Citiraj ovu publikaciju:

Pejanović-Škobić, Nataša; Marković, Ivana; Božina, Nada; Bašić, Silvio
Lack of association of SCN2A rs17183814 polymorphism with the efficacy of lamotrigine monotherapy in patients with focal epilepsy from Herzegovina area, Bosnia and Herzegovina // Epilepsy research, 158 (2019), 106221, 4 doi:10.1016/j.eplepsyres.2019.106221 (međunarodna recenzija, članak, znanstveni)
Pejanović-Škobić, N., Marković, I., Božina, N. & Bašić, S. (2019) Lack of association of SCN2A rs17183814 polymorphism with the efficacy of lamotrigine monotherapy in patients with focal epilepsy from Herzegovina area, Bosnia and Herzegovina. Epilepsy research, 158, 106221, 4 doi:10.1016/j.eplepsyres.2019.106221.
@article{article, author = {Pejanovi\'{c}-\v{S}kobi\'{c}, Nata\v{s}a and Markovi\'{c}, Ivana and Bo\v{z}ina, Nada and Ba\v{s}i\'{c}, Silvio}, year = {2019}, pages = {4}, DOI = {10.1016/j.eplepsyres.2019.106221}, chapter = {106221}, keywords = {Epilepsy, Gene polymorphism, SCN2A, Lamotrigine}, journal = {Epilepsy research}, doi = {10.1016/j.eplepsyres.2019.106221}, volume = {158}, issn = {0920-1211}, title = {Lack of association of SCN2A rs17183814 polymorphism with the efficacy of lamotrigine monotherapy in patients with focal epilepsy from Herzegovina area, Bosnia and Herzegovina}, keyword = {Epilepsy, Gene polymorphism, SCN2A, Lamotrigine}, chapternumber = {106221} }
@article{article, author = {Pejanovi\'{c}-\v{S}kobi\'{c}, Nata\v{s}a and Markovi\'{c}, Ivana and Bo\v{z}ina, Nada and Ba\v{s}i\'{c}, Silvio}, year = {2019}, pages = {4}, DOI = {10.1016/j.eplepsyres.2019.106221}, chapter = {106221}, keywords = {Epilepsy, Gene polymorphism, SCN2A, Lamotrigine}, journal = {Epilepsy research}, doi = {10.1016/j.eplepsyres.2019.106221}, volume = {158}, issn = {0920-1211}, title = {Lack of association of SCN2A rs17183814 polymorphism with the efficacy of lamotrigine monotherapy in patients with focal epilepsy from Herzegovina area, Bosnia and Herzegovina}, keyword = {Epilepsy, Gene polymorphism, SCN2A, Lamotrigine}, chapternumber = {106221} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE

Citati:

    Altmetrijski pokazatelji:


    Podijeli:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font
    CROSBI koristi kolačiće (cookies) kako bi poboljšao funkcionalnost stranice.